General form of registration statement for all companies including face-amount certificate companies

Stockholders' Equity (Details Narrative)

v3.20.2
Stockholders' Equity (Details Narrative) - USD ($)
Jun. 18, 2020
Sep. 30, 2019
Jun. 30, 2020
Jun. 25, 2020
Jun. 24, 2020
Dec. 31, 2019
Aug. 31, 2019
Dec. 31, 2018
Debt conversion price per share           $ 14.28    
Common stock, shares authorized     30,000,000 30,000,000 100,000,000 100,000,000 10,000,000 350,000,000
Preferred stock, shares issued            
Preferred stock, shares outstanding            
Pledge Agreement with PoC [Member]                
Reduced clinical trial funding commitment   $ 900,000            
Number of pledged shares forfeited   56,640            
Warrants to purchase common stock, forfeited   56,640            
2018 Private Placement Transactions [Member]                
Debt conversion price per share     $ 14.28          
Number of common stock issued 28,971